Send Message

Xi'an Libang Pharmaceutical Co., Ltd.

english

français

Deutsch

Italiano

русский

Español

português

Nederlandse

ελληνικά

日本語

한국어



home

about us

Company Profile

factory tour

quality control

FAQ

products

Diatrizoic Acid

Fulvestrant

Meglumine

Melphalan

Nicorandil

Propofol

Tranexamic Acid

Tolperisone Hydrochloride

Lecithin

Lipid Emulsion

Succinylcholine Chloride

Other and Cardiovascular Series

others

blogs

solutions

video

contact us

quote

Home

blog

Libang Pharmaceutical was awarded "Independent Innovation Demonstration Unit, Special Contribution Enterprise, and Advanced Manufacturing Excellent Enterprise"

The most beautiful April day in the world lives up to the spring and the times. On the afternoon of April 20th, the Xi'an High-tech Zone 2017 Enterprise Commendation Conference and China Hard Technology Innovation and Entrepreneurship Listed Enterprise Release Ceremony was held in the Conference ...

02-03-2023
Libang Pharmaceutical won two awards in the "Most Influential List of China's Pharmaceutical Industry in 2017"

On June 25, the "2017 China Pharmaceutical Industry Most Influential List Release Conference and the Ninth China Pharmaceutical Industry Development Summit Forum" sponsored by the All-China Federation of Industry and Commerce Pharmaceutical Industry Chamber of Commerce was held in Lanzhou. Nearly 1...

02-03-2023
Libang Pharmaceutical was selected as the TOP100 Chinese Chemical Pharmaceutical Enterprises in 2018

On July 15, the "2019 National Pharmacy Week and China Pharmaceutical Innovation and Development Conference" kicked off in Jinan. With the theme of "Value Reconstruction—Searching for Growth, Expanding Boundaries, and Exploring the Future", the conference presented participants with a profound ...

02-03-2023
Shugammadex Sodium Injection was included in the National Drug List of Basic Medical Insurance

On January 18th, 2023, the National Medical Insurance Bureau and the Ministry of Human Resources and Social Security issued a notice on the National Drug List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2022), and our company's product Shugammadex geng Glucose Sodium ...

02-02-2023

1